
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Most popular articles from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com</link>
        <description>Most popular articles from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Angelina Jolie&apos;s fearless but flawed message</title>
          <description>Angelina Jolie&apos;s story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful</description>
          <link>http://www.mmm-online.com/angelina-jolies-fearless-but-flawed-message/article/293794/</link>
          <pubDate>Fri, 17 May 2013 16:18:43 GMT</pubDate>
          <itunes:summary>Angelina Jolie&apos;s story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharmas dial back reprints spend, floor it on digital to reach HCPs</title>
          <description>Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.</description>
          <link>http://www.mmm-online.com/pharmas-dial-back-reprints-spend-floor-it-on-digital-to-reach-hcps/article/294121/</link>
          <pubDate>Mon, 20 May 2013 18:25:25 GMT</pubDate>
          <itunes:summary>Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Purdue puts Intermezzo DTC to bed</title>
          <description>Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.</description>
          <link>http://www.mmm-online.com/purdue-puts-intermezzo-dtc-to-bed/article/293546/</link>
          <pubDate>Thu, 16 May 2013 20:36:00 GMT</pubDate>
          <itunes:summary>Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharmas are cool with YouTube but fear Twitter</title>
          <description>Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.</description>
          <link>http://www.mmm-online.com/pharmas-are-cool-with-youtube-but-fear-twitter/article/293534/</link>
          <pubDate>Wed, 15 May 2013 19:44:39 GMT</pubDate>
          <itunes:summary>Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Merck&apos;s Heller on how to get more women into the C-suite</title>
          <description>Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.</description>
          <link>http://www.mmm-online.com/mercks-heller-on-how-to-get-more-women-into-the-c-suite/article/293326/</link>
          <pubDate>Tue, 14 May 2013 17:51:44 GMT</pubDate>
          <itunes:summary>Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Culture of innovation has a sales value, study says</title>
          <description>Why executives evaluating biotech acquisitions shouldn&apos;t overlook the cultural dimension: A new paper finds a link to revenue performance.</description>
          <link>http://www.mmm-online.com/culture-of-innovation-has-a-sales-value-study-says/article/293086/</link>
          <pubDate>Mon, 13 May 2013 15:15:03 GMT</pubDate>
          <itunes:summary>Why executives evaluating biotech acquisitions shouldn&apos;t overlook the cultural dimension: A new paper finds a link to revenue performance.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Astellas shutters OSI and Perseid, lets 200 US staff go in R&amp;D reorg</title>
          <description>It was a particularly grim Monday for 200 Astellas employees in the US, who were informed that they were being let go and it was their last day with the company.</description>
          <link>http://www.mmm-online.com/astellas-shutters-osi-and-perseid-lets-200-us-staff-go-in-rd-reorg/article/293346/</link>
          <pubDate>Tue, 14 May 2013 18:56:20 GMT</pubDate>
          <itunes:summary>It was a particularly grim Monday for 200 Astellas employees in the US, who were informed that they were being let go and it was their last day with the company.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Ex-NFLer, Sanofi talk anaphylaxis</title>
          <description>The company&apos;s latest outreach, an Auvi-Q promotion, breaks down allergy management into sports playbook presentation.</description>
          <link>http://www.mmm-online.com/ex-nfler-sanofi-talk-anaphylaxis/article/294018/</link>
          <pubDate>Mon, 20 May 2013 14:58:33 GMT</pubDate>
          <itunes:summary>The company&apos;s latest outreach, an Auvi-Q promotion, breaks down allergy management into sports playbook presentation.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>FDA move gives Purdue edge in painkiller market</title>
          <description>Generic Opana ER got the go-ahead from FDA, exposing the drugmaker to generic competition -- unlike Purdue, whose tamper-proof painkiller won standalone status.</description>
          <link>http://www.mmm-online.com/fda-move-gives-purdue-edge-in-painkiller-market/article/293166/</link>
          <pubDate>Mon, 13 May 2013 17:25:56 GMT</pubDate>
          <itunes:summary>Generic Opana ER got the go-ahead from FDA, exposing the drugmaker to generic competition -- unlike Purdue, whose tamper-proof painkiller won standalone status.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Tarceva diagnostic brings new indication</title>
          <description>Tarceva picks up a first-line indication and a companion diagnostic</description>
          <link>http://www.mmm-online.com/tarceva-diagnostic-brings-new-indication/article/293523/</link>
          <pubDate>Wed, 15 May 2013 16:45:18 GMT</pubDate>
          <itunes:summary>Tarceva picks up a first-line indication and a companion diagnostic</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>J&amp;J&apos;s Janssen looks to the margins with hep C agent</title>
          <description>J&amp;J scored an unexpected &quot;priority review status&quot; for its HCV agent simeprivir, whose initial approval is expected to be with interferon.</description>
          <link>http://www.mmm-online.com/jjs-janssen-looks-to-the-margins-with-hep-c-agent/article/293322/</link>
          <pubDate>Tue, 14 May 2013 17:10:47 GMT</pubDate>
          <itunes:summary>J&amp;J scored an unexpected &quot;priority review status&quot; for its HCV agent simeprivir, whose initial approval is expected to be with interferon.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Runs and ribbons don&apos;t do much for advanced breast cancer sufferers, survey finds</title>
          <description>A Novartis survey finds many women with advanced breast cancer feel left out by an awareness movement focused on prevention, early detection and pink merchandise.</description>
          <link>http://www.mmm-online.com/runs-and-ribbons-dont-do-much-for-advanced-breast-cancer-sufferers-survey-finds/article/294287/</link>
          <pubDate>Tue, 21 May 2013 17:22:46 GMT</pubDate>
          <itunes:summary>A Novartis survey finds many women with advanced breast cancer feel left out by an awareness movement focused on prevention, early detection and pink merchandise.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Roche&apos;s Rituxan successor receives high marks</title>
          <description>Genentech&apos;s blockbuster follow-up shows promise in preliminary Phase III data</description>
          <link>http://www.mmm-online.com/roches-rituxan-successor-receives-high-marks/article/293680/</link>
          <pubDate>Thu, 16 May 2013 17:39:43 GMT</pubDate>
          <itunes:summary>Genentech&apos;s blockbuster follow-up shows promise in preliminary Phase III data</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>US awards GSK $200M to fight &quot;superbugs&quot;</title>
          <description>GSK and the US Department of Health and Human Services inked a deal to fund development of new antibiotics, an area where clinicians face a dearth of new options.</description>
          <link>http://www.mmm-online.com/us-awards-gsk-200m-to-fight-superbugs/article/294548/</link>
          <pubDate>Thu, 23 May 2013 11:50:40 GMT</pubDate>
          <itunes:summary>GSK and the US Department of Health and Human Services inked a deal to fund development of new antibiotics, an area where clinicians face a dearth of new options.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Belushi, Savient observe Gout Awareness Day</title>
          <description>The actor and patient heads up a roundtable posted on the advocacy site CreakyJoints.</description>
          <link>http://www.mmm-online.com/belushi-savient-observe-gout-awareness-day/article/294381/</link>
          <pubDate>Wed, 22 May 2013 14:51:10 GMT</pubDate>
          <itunes:summary>The actor and patient heads up a roundtable posted on the advocacy site CreakyJoints.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Google revamps scramble the SEO playbook</title>
          <description>Pharmas need to start fine-tuning paid search and producing &quot;liquid content&quot; that moves fluidly between screens, said Google&apos;s David Blair at our first MM&amp;M Skill Sets Live session</description>
          <link>http://www.mmm-online.com/google-revamps-scramble-the-seo-playbook/article/294753/</link>
          <pubDate>Fri, 24 May 2013 15:24:24 GMT</pubDate>
          <itunes:summary>Pharmas need to start fine-tuning paid search and producing &quot;liquid content&quot; that moves fluidly between screens, said Google&apos;s David Blair at our first MM&amp;M Skill Sets Live session</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>FDA gut-checks DTC clarity</title>
          <description>The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.</description>
          <link>http://www.mmm-online.com/fda-gut-checks-dtc-clarity/article/293327/</link>
          <pubDate>Tue, 14 May 2013 17:50:23 GMT</pubDate>
          <itunes:summary>The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Mayo device helps monitor heart patients from afar</title>
          <description>Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world.</description>
          <link>http://www.mmm-online.com/mayo-device-helps-monitor-heart-patients-from-afar/article/294386/</link>
          <pubDate>Wed, 22 May 2013 14:59:55 GMT</pubDate>
          <itunes:summary>Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business Briefs: Merck and Forest Labs</title>
          <description>Merck&apos;s proposed insomnia drug scores a thumbs-up from an FDA advisory panel, and long-time Forest Labs CEO Howard Solomon announces his coming retirement.</description>
          <link>http://www.mmm-online.com/business-briefs-merck-and-forest-labs/article/294660/</link>
          <pubDate>Thu, 23 May 2013 18:27:46 GMT</pubDate>
          <itunes:summary>Merck&apos;s proposed insomnia drug scores a thumbs-up from an FDA advisory panel, and long-time Forest Labs CEO Howard Solomon announces his coming retirement.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Don&apos;t throw the creative baby out with the metrics bathwater!</title>
          <description>Learning to trust your instincts when you come upon a good idea may allow you to establish industry metrics instead of waiting to be guided by them.</description>
          <link>http://www.mmm-online.com/dont-throw-the-creative-baby-out-with-the-metrics-bathwater/article/294126/</link>
          <pubDate>Mon, 20 May 2013 19:40:22 GMT</pubDate>
          <itunes:summary>Learning to trust your instincts when you come upon a good idea may allow you to establish industry metrics instead of waiting to be guided by them.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  